Importantly, mechanistically, we found purine-rich box1 (PU.1), a blood cell lineage specifying a transcription factor encoded by SPI1, to be a potential target of TK216 in pediatric AML and B-ALL cells. This evidence concerns the gene SPI1 and acute myeloid leukemia.